drugset / Trial / NCT02347358

Mechanical Opening Device Implantation Following Intravenous r-tPA for Recanalization in Acute Ischemic Stroke

NCT02347358

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is to test a hypothesis that temporary implantation of JRecanTM blood flow recanalisation device within 6.5 hours of symptom onset of acute ischemic stroke due to a major intracranial artery occlusion following IV r-tPA can provide a greater rate of early successful recanalisation than treatment of IV r-tPA alone.

Timeline

Start
2015-02
Primary completion
2017-01
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alteplase Protein / enzyme biologic Intravenous

Indications